- Home
- IZM vs BOLD Comparison
IZM vs BOLD Comparison
Compare IZM & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- BOLD
- Stock Information
- Founded
- IZM 2011
- BOLD 2018
- Country
- IZM China
- BOLD United States
- Employees
- IZM N/A
- BOLD N/A
- Industry
- IZM Consumer Electronics/Video Chains
- BOLD
- Sector
- IZM Consumer Discretionary
- BOLD
- Exchange
- IZM Nasdaq
- BOLD Nasdaq
- Market Cap
- IZM 31.8M
- BOLD 24.4M
- IPO Year
- IZM 2023
- BOLD 2024
- Fundamental
- Price
- IZM $2.51
- BOLD $1.18
- Analyst Decision
- IZM
- BOLD Buy
- Analyst Count
- IZM 0
- BOLD 3
- Target Price
- IZM N/A
- BOLD $4.00
- AVG Volume (30 Days)
- IZM 31.8K
- BOLD 276.3K
- Earning Date
- IZM 07-29-2025
- BOLD 08-11-2025
- Dividend Yield
- IZM N/A
- BOLD N/A
- EPS Growth
- IZM N/A
- BOLD N/A
- EPS
- IZM N/A
- BOLD N/A
- Revenue
- IZM $180,553,977.00
- BOLD N/A
- Revenue This Year
- IZM N/A
- BOLD N/A
- Revenue Next Year
- IZM N/A
- BOLD N/A
- P/E Ratio
- IZM N/A
- BOLD N/A
- Revenue Growth
- IZM N/A
- BOLD N/A
- 52 Week Low
- IZM $1.18
- BOLD $1.00
- 52 Week High
- IZM $3.19
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- IZM 50.31
- BOLD N/A
- Support Level
- IZM $2.50
- BOLD N/A
- Resistance Level
- IZM $2.65
- BOLD N/A
- Average True Range (ATR)
- IZM 0.10
- BOLD 0.00
- MACD
- IZM -0.02
- BOLD 0.00
- Stochastic Oscillator
- IZM 32.35
- BOLD 0.00
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.